The growth of the market in this region is ascribed to increasing life science research activities in Asia Pacific, and growing number of drug discovery programs through academic–industrial partnerships. However, the lack of skilled professionals hinders the market growth in this region.
Leading Asian economies, specifically China and India, with increased investments in biotechnology and drug discovery contribute significantly to the label free detection market in Asia Pacific. Several Asian countries do not have established business models but have the talent and scientific expertise to develop strong local biotechnology industries. Thus, the number of mergers, collaborations, and partnerships is increasing in these emerging countries. Many Asian economies have altered regulations, policies, and guidelines to support investments, innovation, and commercialization.
Over the years, the pharmaceutical industry in China has shifted its primary focus to research & development of innovative treatments from the manufacturing of generics. Many pharma and biopharmaceutical companies, such as AstraZeneca, GlaxoSmithKline, Sanofi, and Ferring Pharmaceuticals, have announced their plans to invest in life science R&D activities in emerging economies in Asia Pacific in the future, which is likely to provide lucrative opportunities for the label free detection market players in the coming years.
• In July 2018, Ferring Pharmaceuticals laid the foundation for its R&D laboratory and manufacturing facility at Genome Valley, Hyderabad, India. The new facility added to the group’s global R&D capabilities and will conduct novel research for the globally emerging healthcare challenges.
• In July 2018, Sanofi, a global biopharmaceutical company, announced to establish a global R&D operations hub in Chengdu, China. The company plans to use the hub to tackle therapeutic areas, including vaccines, immunology and inflammation, and cardiovascular diseases.
• In November 2019, AstraZeneca announced large-scale initiatives in China to drive medicine R&D. The initiatives consist of establishing a new global R&D center and artificial intelligence innovation center in Shanghai, China.
Label free detection technologies provide revolutionary advancements for life science research applications. Thus, increasing life science research activities in emerging economies would accelerate the growth of the label free detection market in these countries during the forecast period.
The Asia Pacific label free detection market based on the product is segmented into instruments and consumables. Based on technology, the Asia Pacific label free detection market is segmented into surface plasmon resonance, bio-layer interferometry, isothermal titration calorimetry, differential scanning calorimetry, and other LFD technologies. The Asia Pacific label free detection market, based on application is segmented into binding kinetics, binding thermodynamics, endogenous receptor detection, hit confirmation, lead generation, and other applications. The Asia Pacific label free detection market, based on end user is segmented into pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations and other end users. Geographically, the Asia Pacific label free detection market can be divided into China, Japan, India, South Korea, Australia and Rest of Asia Pacific.
General Electric, Perkin Elmer, Inc., AMETEK Inc., F. HOFFMANN-LA ROCHE LTD., Spectris, METTLER TOLEDO, Agilent Technologies, Inc., Waters Corporation, Sartorius AG and Corning Incorporated are among the leading companies operating in the Asia Pacific label free detection market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 106.08 Million |
| Market Size by 2028 | US$ 192.41 Million |
| CAGR (2021 - 2028) | 8.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Label Free Detection Market is valued at US$ 106.08 Million in 2021, it is projected to reach US$ 192.41 Million by 2028.
As per our report Asia Pacific Label Free Detection Market, the market size is valued at US$ 106.08 Million in 2021, projecting it to reach US$ 192.41 Million by 2028. This translates to a CAGR of approximately 8.9% during the forecast period.
The Asia Pacific Label Free Detection Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Label Free Detection Market report:
The Asia Pacific Label Free Detection Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Label Free Detection Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Label Free Detection Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Label Free Detection Market
